GERD May Increase Risk for Subsequent Non–Small Cell Lung Cancer
Investigators studied the association between gastroesophageal reflux disease and non–small lung cancer in a retrospective case-control study.
Investigators studied the association between gastroesophageal reflux disease and non–small lung cancer in a retrospective case-control study.
A reduction in urinary citrate levels may be the mechanism underlying the higher incidence of kidney stones in patients taking PPIs, according to investigators.
End-stage lung disease may significantly increase the risk for gastroesophageal reflux disease (GERD) in patients undergoing lung transplant without primary esophageal disease.
The bile acid sequestrant was designed to be maintained in the stomach over an extended period of time where it was expected to intercept bile before it reached the esophagus.
Regular use of proton pump inhibitors is associated with an increased risk for type 2 diabetes.
Acid exposure measured via reflux monitoring can be predicative of a patient’s ability to discontinue PPI use without symptom escalation.
For patients with advanced urothelial cancer treated with atezolizumab, proton pump inhibitor use is a negative prognostic marker.
Coffee, tea, and soda are associated with an increased risk for gastroesophageal reflux symptoms among middle-aged women.
Patients undergoing sleeve gastrectomy sometimes develop gastroesophageal reflux disease, a major risk factor for Barrett’s esophagus; therefore, researchers investigated whether patients with SG have a high rate of BE.
Investigators sought to determine whether peroral endoscopic myotomy is safe in patients receiving antithrombotic therapy and examined its clinical success and postprocedural rates of GERD.